Skip to main content
HLB Pep Co., Ltd. logo

HLB Pep Co., Ltd. — Investor Relations & Filings

Ticker · 196300 ISIN · KR7196300008 KO Manufacturing
Open in API
Filings indexed 276 across all filing types
Latest filing 2024-07-05 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 196300

About HLB Pep Co., Ltd.

http://hlbpep.co.kr/eng/main/

HLB Pep Co., Ltd. is a biopharmaceutical company specializing in the research, development, and production of peptide-based biomaterials and new drugs. The company's core activities include the manufacturing of peptide Active Pharmaceutical Ingredients (APIs) in a GMP-certified facility. It offers a range of products and services, including generic peptides, custom peptide synthesis for research and development, and a catalog of approximately 1,000 research peptides such as hormones and neuropeptides. HLB Pep focuses on discovering new drug candidates and aims to commercialize them through technology transfer.

Recent filings

Filing Released Lang Actions
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to specific employees and executives, including the number of shares, exercise price, and vesting conditions. This type of disclosure regarding capital structure changes and equity-based compensation falls under the category of 'Share Issue/Capital Change' (SHA) as it relates to the potential future issuance of shares through stock option exercises.
2024-07-05 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a correction (정정신고) of a previous filing. It details the granting of stock options to employees, including the number of shares, fair value, and exercise conditions. In the context of corporate filings, reports regarding the issuance of stock options or changes in capital structure that do not fit into specific categories like 'Director's Dealing' or 'Share Issue' are classified as general regulatory filings (RNS).
2024-07-05 Korean
기타시장안내 (업종변경 안내)
Regulatory Filings Classification · 100% confidence The document is a short announcement from the Korea Exchange regarding a change in the company's industry classification code due to a revision in the Korean Standard Industrial Classification. It does not fit into specific financial reporting categories like 10-K, IR, or ER, and is not a report publication announcement. Therefore, it falls under the general regulatory filing category.
2024-06-28 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a regulatory filing regarding the 'Resolution to Convene a General Meeting of Shareholders' (주주총회소집결의) and a subsequent amendment (정정신고) to that notice. It outlines the agenda items for an upcoming Extraordinary General Meeting, including amendments to articles of incorporation and stock option grants. Since this document serves as the formal notice and solicitation of information for shareholders regarding an upcoming meeting, it falls under the Proxy Solicitation & Information Statement category.
2024-06-19 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Extraordinary General Meeting' (주주총회소집공고) issued by Anygen Co., Ltd. It contains the meeting agenda, including proposed amendments to the articles of incorporation, stock option grants, and executive retirement pay regulations. This document is a formal proxy statement sent to shareholders to provide information and request votes for an upcoming meeting, which fits the definition of a Proxy Solicitation & Information Statement (PSI).
2024-06-19 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit votes from shareholders for an upcoming general meeting (in this case, an Extraordinary General Meeting). It contains detailed agenda items such as amendments to the articles of incorporation, stock option grants, and executive retirement pay regulations. This falls under the 'Proxy Solicitation & Information Statement' category.
2024-06-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.